‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
Speaking of SurgOnc
Symptom burden at the end-of-life for neuroendocrine tumors: an analysis of 2,579 prospectively collected patient-reported outcomes
30
00:00:00
/ 00:07:28
30